NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

NEXTURNBIOSCIENCE Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	34,199	33,999	51,872	65,856	200,064	124,142
Market Cap Growth	-3.16%	-34.46%	-21.23%	-67.08%	61.16%	344.80%
Enterprise Value	155,536	84,865	86,701	126,455	191,439	117,721
Last Close Price	2370.00	2795.00	5520.00	8475.00	31200.00	19833.33
PE Ratio	-	-	5.36	-	-	-
PS Ratio	0.90	1.08	1.26	2.81	11.79	12.82
PB Ratio	0.15	0.25	0.38	0.61	2.16	1.28
P/TBV Ratio	0.23	0.25	0.38	0.63	2.16	1.29
P/FCF Ratio	10.86	-	-	-	62.58	-
P/OCF Ratio	9.05	-	-	-	54.60	526.16
EV/Sales Ratio	4.11	2.68	2.10	5.39	11.28	12.15
EV/EBITDA Ratio	-	149.66	118.47	-	-	-
EV/FCF Ratio	49.37	-	-	-	59.88	-
Debt / Equity Ratio	0.40	0.60	0.56	0.70	0.31	0
Debt / EBITDA Ratio	39.35	143.23	104.90	-	-	-
Debt / FCF Ratio	29.58	-	-	-	8.88	-
Asset Turnover	0.13	0.13	0.19	0.14	0.14	-
Inventory Turnover	1.43	3.39	4.84	2.93	1.98	-
Quick Ratio	0.66	1.77	0.41	1.84	1.05	27.58
Current Ratio	1.00	2.33	0.50	2.23	1.18	32.29
Return on Equity (ROE)	0.45%	-9.47%	7.53%	-4.85%	-4.68%	-
Return on Assets (ROA)	-0.00%	-0.38%	-0.36%	-1.67%	-1.25%	-
Return on Capital (ROIC)	-0.00%	-0.42%	-0.40%	-1.86%	-1.37%	-
Earnings Yield	-1.51%	-38.25%	18.66%	-7.12%	-2.22%	-1.96%
FCF Yield	9.21%	-5.26%	-5.88%	-2.14%	1.60%	-0.79%
Buyback Yield / Dilution	-23.97%	-8.38%	-48.59%	-5.86%	-	-
Total Shareholder Return	-	-8.38%	-48.59%	-5.86%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.